Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Classifica tra le azioni #178
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Prezzo delle azioni
$44.60
Capitalizzazione di mercato
$108.62B
Variazione (1 giorno)
-1.63%
Variazione (1 anno)
-21.62%
Paese
FR
Scambia Sanofi (SNY)

Categoria

EPS per Sanofi (SNY)
EPS al December 2025 TTM: $2.38
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Sanofi, l’EPS attuale della società (TTM) è $2.38. Alla fine del 2024, la società aveva un EPS di $2.28 una diminuzione rispetto a rispetto a quello del 2023, che era di $2.38.
Storico EPS per Sanofi da 2000 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $2.38 0.07%
2025 $2.38 4.52%
2024 $2.28 -4.12%
2023 $2.38 -30.54%
2022 $3.42 20.85%
2021 $2.83 -52.65%
2020 $5.98 367.50%
2019 $1.28 -35.66%
2018 $1.99 10.45%
2017 $1.80 -6.52%
2016 $1.93 8.13%
2015 $1.78 -11.87%
2014 $2.02 4.21%
2013 $1.94 -20.54%
2012 $2.44 -12.32%
2011 $2.78 -0.87%
2010 $2.81 -3.06%
2009 $2.90 -24.43%
2008 $3.83 33.77%
2007 $2.87 46.14%
2006 $1.96 97.53%
2005 $0.99 -33.46%
2004 $1.49 -19.97%
2003 $1.86 46.78%
2002 $1.27 31.05%
2001 $0.97 52.20%
2000 $0.64 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$23.00 865.70%
US
$13.20 454.23%
GB
$11.10 366.05%
US
$2.37 -0.49%
US
$7.20 202.31%
CH